Клинические рекомендации / Российские+рекомендации+по+ФП+2017

КЛИНИЧЕСКИЕРЕКОМЕНДАЦИИПОПРОВЕДЕНИЮ ЭЛЕКТРОФИЗИОЛОГИЧЕСКИХПРОЦЕДУР УПАЦИЕНТОВСНАРУШЕНИЯМИРИТМАСЕРДЦА

Списоклитературы

1.Бокерия Л. А. —​Тахиаритмии:Диагностикаихирургическоеле- чение—​М:Медицина,1989.

2.Бокерия Л. А.,Ревишвили А. Ш. Катетернаяабляциятахиарит-мий: современное состояние проблемы и перспективы разви-тия // Вестникаритмологии—​1988. —№ 8. —​С.70.

3.Ревишвили А. Ш. Электрофизиологическаядиагностикаихи-рур- гическоелечениенаджелудочковыхтахиаритмий//Карди-ология № 11–1990,с.56–59.

4.AkhtarM,AchordJL,ReynoldsWA.Clinicalcompetenceininvasive cardiac electrophysiological studies. ACP/ACC/AHA Task Force on ClinicalPrivilegesinCardiology.JAmCollCardiol1994;23:1258–61.

5.Blomström-Lundqvist and Scheinman ММ et al. ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias—Executive​SummaryAReportoftheAmericanCollege of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for PracticeGuidelines(WritingCommitteetoDevelopGuidelinesforthe ManagementofPatientsWithSupraventricularArrhythmias)

6.Crawford MH, Bernstein SJ, Deedwania PC et al. ACC/AHA guidelinesforambulatoryelectrocardiography:executivesummary and recommendations, a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography).Circulation1999;100:886–93.

7.Faster V,RydenLE,AsingerRWetal.ACC/AHA/ESCguidelinesforthe managementofpatientswithatrialfibrillation:executivesummary: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European SocietyofCardiologyCommitteeforPracticeGuidelinesandPolicy Conferences(CommitteetoDevelopGuidelinesfortheManagement ofPatientsWithAtrialFibrillation)Developedincol-laborationwiththe NorthAmericanSocietyofPacingandElectrophysiology.Circulation 2001;104:2118–50.

8.Flowers NC, Abildskov JA, Armstrong WF, et al. ACC policy statement: recommended guidelines for training in adult clinical cardiacelectrophysiology.Electrophysiology/Electrocardiography

411

ГЛАВА3

Subcommittee, American College of Cardiology. J Am Coll Cardiol 1991;18:637–40.

9.Josephson ME, Maloney JD, Barold SS. Guidelines for training in adult cardiovascular medicine. Core Cardiology Training Symposium(COCATS) Task Force 6: training in specialized electrophysiology, cardiac pacing and arrhythmia management. J AmCollCardiol1995;25:23–6.

10.Scheinman MM, Huang S. The 1998 NASPE prospective catheter ablationregistry.PacingClinElectrophysiol2000;23:1020–8.

11.Zipes DP, DiMarco JP, Gillette PC et al. Guidelines for clinical intracardiacelectrophysiologicalandcatheterablationprocedures: a report of the American College of Cardiology/ American Heart AssociationTaskForceonPracticeGuidelines(CommitteeonClinical IntracardiacElectrophysiologicandCatheterAblationProcedures), developedincollaborationwiththeNorthAmericanSocietyofPacing andElectrophysiology.JAmCollCardiol1995;26:555–73

12.2015ACC/AHA/HRSGuidelinefortheManagementofAdultPatients WithSupraventricularTachycardiaCirculation.2016;133:e506-e574

13.2015ESCGuidelinesforthemanagementofpatientswithventricular arrhythmiasandthepreventionofsuddencardiacdeathEurHeartJ (2015)36(41):2793–2867.

14.StraussHC,BiggerJTJr,SaroffAL,GiardinaEG.Electrophysiologic evaluation of sinus node function in patients with sinus node dysfunction.Circulation.1976;53:763–776.

15.Strauss HC, Saroff AL, Bigger JT Jr, Giardina EG. Premature atrial stimulation as a key to the understanding of sinoatrial conduction in man: presentation of data and critical review of the literature. Circulation.1973;47:86–93

16.Breithardt G, Seipel L, Loogen F. Sinus node recovery time and calculatedsinoatrialconductiontimeinnormalsubjectsandpatients withsinusnodedysfunction.Circulation.1977;56:43–50.

17.GannD,TolentinoA,SametP. Electrophysiologicevaluationofelderly patients with sinus bradycardia: a long-term follow-up study. Ann InternMed.1979;90:24–29.

18.Damato AN, Lau SH, Helfant R, Stein E, Patton RD, Scherlag BJ, Berkowitz WD. A study of heart block in man using His bundle recordings.Circulation.1969;39:297–305.

19.Zipes DP. Second-degree atrioventricular block. Circulation. 1979;60:465–472.

412

КЛИНИЧЕСКИЕРЕКОМЕНДАЦИИПОПРОВЕДЕНИЮ ЭЛЕКТРОФИЗИОЛОГИЧЕСКИХПРОЦЕДУР УПАЦИЕНТОВСНАРУШЕНИЯМИРИТМАСЕРДЦА

20.Strasberg B, Amat-Y-Leon F, Dhingra RC, Palileo E, Swiryn S, Bauernfeind R, Wyndham C, Rosen KM. Natural history of chronic second-degreeatrioventricularnodalblock.Circulation.1981;63:1043– 1049.

21.NarulaOS,ScherlagBJ,JavierRP,HildnerFJ,SametP. Analysisofthe A-V conduction defect in complete heart block utilizing His bundle electrograms.Circulation.1970;41:437–448.

22.DhingraRC,PalileoE,StrasbergB,SwirynS,BauerfeindRA,Wyndham CR, Rosen KM. Significance of the HV interval in 517 patients with chronicbifascicularblock.Circulation.1981;64:1265–1271.

23.Scheinman MM, Peters RW, Modin G, Brennan M, Mies C, O’Young J. Prognostic value of infranodal conduction time in patients with chronicbundlebranchblock.Circulation.1977;56:240–244.

24.Dhingra RC, Wyndham C, Bauernfeind R, Swiryn S, Deedwania PC, Smith T, Denes P, Rosen KM. Significance of block distal to the His bundleinducedbyatrialpacinginpatientswithchronicbifascicular block.Circulation.1979;60:1455–1464.

25.FischGR,ZipesDP,FischC. Bundlebranchblockandsuddendeath. ProgCardiovascDis.1980;23:187–224.

26.LimSH,Anantharaman V,TeoWS,etal.Comparisonoftreatmentof supraventriculartachycardiabyValsalvamaneuverandcarotidsinus massage.AnnEmergMed.1998;31:30–5.

27.Luber S, Brady WJ, Joyce T, et al. Paroxysmal supraventricular tachycardia:outcomeafterEDcare.AmJEmergMed.2001;19:40–2.

28.Waxman MB, Wald RW, Sharma AD, et al. Vagal techniques for terminationofparoxysmalsupraventriculartachycardia.AmJCardiol. 1980;46:655–64.

29.DiMarco JP, Miles W, Akhtar M, et al. Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil.Assessmentinplacebo-controlled,multicentertrials.The AdenosineforPSVTStudyGroup.AnnInternMed.1990;113:104–10.

30.Cairns CB, Niemann JT. Intravenous adenosine in the emergency departmentmanagementofparoxysmalsupraventriculartachycardia. AnnEmergMed.1991;20:717–21.

31.Brady WJ, DeBehnke DJ, Wickman LL, et al. Treatment of out-of- hospitalsupraventriculartachycardia:adenosinevsverapamil.Acad EmergMed.1996;3:574–85.

413

ГЛАВА3

32.GauscheM,PersseDE,SugarmanT,etal.Adenosinefortheprehospital treatment of paroxysmal supraventricular tachycardia. Ann Emerg Med.1994;24:183–9.

33.Madsen CD, Pointer JE, Lynch TG. A comparison of adenosine and verapamil for the treatment of supraventricular tachycardia in the prehospitalsetting.AnnEmergMed.1995;25:649–55.

34.McCabeJL,AdharGC,MenegazziJJ,etal.Intravenousadenosinein theprehospitaltreatmentofparoxysmalsupraventriculartachycardia. AnnEmergMed.1992;21:358–61.

35.RankinAC,OldroydKG,ChongE,etal.Valueandlimitationsofadenosine inthediagnosisandtreatmentofnarrowandbroadcomplextachycardias. BrHeartJ.1989;62:195–203.

36.Lim SH, Anantharaman V, Teo WS, et al. Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergencytreatmentofsupraventriculartachycardia.Resuscitation. 2009;80:523–8.

37.Adenoscan IV(adenosineinjection)forrapidbolusintravenoususe. U. S. Foodand DrugAdministration.2015.Availableat:http://www. accessdata.fda.gov/drugsatfda_docs/label/2011/019937s026lbl. pdf. Accessed July 29, 2015. Roth A, Elkayam I, Shapira I, et al. Effectivenessofprehospitalsynchronousdirect-currentcardioversion forsupraventriculartachyarrhythmiascausingunstablehemodynamic states.AmJCardiol.2003;91:489–91.

38.Stec S, Kryñski T, Kułakowski P. Efficacy of low energy rectilinear biphasiccardioversionforregularatrialtachyarrhythmias.CardiolJ. 2011;18:33–8.

39.LimSH,Anantharaman V,TeoWS.Slow-infusionofcalciumchannel blockers in the emergency management of supraventricular tachycardia.Resuscitation.2002;52:167–74.MauritsonDR,

40.GuptaA,NaikA,VoraA,etal.Comparisonofefficacyofintravenous diltiazemandesmololinterminatingsupraventriculartachycardia.J AssocPhysiciansIndia.1999;47:969–72.

41.Sintetos AL, Roark SF, Smith MS, et al. Incidence of symptomatic tachycardiainuntreatedpatientswithparoxysmalsupraventricular tachycardia.ArchInternMed.1986;146:2205–9.

42.Mauritson DR, Winniford MD, Walker WS, et al. Oral verapamil for paroxysmalsupraventriculartachycardia:along-term,double-blind randomizedtrial.AnnInternMed.1982;96:409–12.

414

КЛИНИЧЕСКИЕРЕКОМЕНДАЦИИПОПРОВЕДЕНИЮ ЭЛЕКТРОФИЗИОЛОГИЧЕСКИХПРОЦЕДУР УПАЦИЕНТОВСНАРУШЕНИЯМИРИТМАСЕРДЦА

43.WinnifordMD,FultonKL,HillisLD.Long-termtherapyofparoxysmal supraventriculartachycardia:arandomized,double-blindcomparison ofdigoxin,propranololandverapamil.AmJCardiol.1984;54:1138–9.

44.Jackman WM, Beckman KJ, McClelland JH, et al. Treatment of supraventricular tachycardia due to atrioventricular nodal reentry, byradiofrequencycatheterablationofslow-pathwayconduction.N EnglJMed.1992;327:313–8.

45.HindricksG. TheMulticentreEuropeanRadiofrequencySurvey(MERFS): complicationsofradiofrequencycatheterablationofarrhythmias.The MulticentreEuropeanRadiofrequencySurvey(MERFS)Investigators of the Working Group on Arrhythmias of the European Society of Cardiology.EurHeartJ.1993;14:1644–53.

46.HindricksG. Incidenceofcompleteatrioventricularblockfollowing attemptedradiofrequencycathetermodificationoftheatrioventricular node in 880 patients. Results of the Multicenter European RadiofrequencySurvey(MERFS)TheWorkingGrouponArrhythmias oftheEuropeanSocietyofCardiology.EurHeartJ.1996;17:82–8.

47.Spector P, Reynolds MR, Calkins H, et al. Metaanalysis of ablation of atrial flutter and supraventricular tachycardia. Am J Cardiol. 2009;104:671–7.

48.Calkins H, Yong P, Miller JM, et al. Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricularjunction:finalresultsofaprospective, multicenter clinicaltrial.TheAtakrMulticenterInvestigatorsGroup.Circulation. 1999;99:262–70.

49.Scheinman MM, Huang S. The 1998 NASPE prospective catheter ablationregistry.PacingClinElectrophysiol.2000;23:1020–8.

50.Cheng CH, Sanders GD, Hlatky MA, et al. Costeffectiveness of radiofrequencyablationforsupraventriculartachycardia.AnnIntern Med.2000;133:864–76.

51.BohnenM,StevensonWG,TedrowUB,etal.Incidenceandpredictors ofmajorcomplicationsfromcontemporarycatheterablationtotreat cardiacarrhythmias.HeartRhythm.2011;8:1661–6.

52.Henthorn R. W., Waldo A. L., Anderson J. L., et al.(1991) Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular TachycardiaStudyGroup.Circulation83:119–125.

53.Dorian P., Naccarelli G. V., Coumel P., et al. (1996) A randomized comparison of flecainide versus verapamil in paroxysmal

415

ГЛАВА3

supraventriculartachycardia.TheFlecainideMulticenterInvestigators Group.AmJCardiol77:89A 95A.

54.Tendera M., Wnuk-Wojnar A.M., Kulakowski P., et al. (2001) Efficacy andsafetyofdofetilideinthepreventionofsymptomaticepisodes ofparoxysmalsupraventriculartachycardia:a6-monthdouble-blind comparisonwithpropafenoneandplacebo.AmHeartJ142:93–98

55.(1995)Arandomized,placebo-controlledtrialofpropafenoneinthe prophylaxisofparoxysmalsupraventriculartachycardiaandparoxysmal atrial fibrillation. UK Propafenone PSVT Study Group. Circulation 92:2550–2557.

56.Chimienti M., Cullen M. T., Casadei G.(1995) Safety of flecainide versuspropafenoneforthelong-termmanagementofsymptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group. Eur Heart J16:1943–1951.

57.Anderson J. L.,Platt M. L.,GuarnieriT.,etal.(1994)Flecainideacetate for paroxysmal supraventricular tachyarrhythmias. The Flecainide SupraventricularTachycardiaStudyGroup.AmJCardiol74:578–584.

58.Pritchett E. L., DaTorre S.D., Platt M. L., et al. (1991) Flecainide acetate treatmentofparoxysmalsupraventriculartachycardia and paroxysmalatrialfibrillation:dose-responsestudies.TheFlecainide SupraventricularTachycardiaStudyGroup.JAmCollCardiol17:297

59.Pritchett E. L., McCarthy E.A., Wilkinson W. E. (1991) Propafenone treatmentofsymptomaticparoxysmalsupraventriculararrhythmias.A randomized,placebo-controlled,crossovertrialinpatientstolerating oraltherapy.AnnInternMed114:539–544.

60.Wanless R. S.,AndersonK.,JoyM.,etal.(1997)Multicentercomparative studyoftheefficacyandsafetyofsotalolintheprophylactictreatment ofpatientswithparoxysmalsupraventriculartachyarrhythmias.Am HeartJ133:441–446.

61.Gambhir D. S., Bhargava M., Nair M., et al. (1996) Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentranttachycardia.IndianHeartJ48:133–137.

62.OlshanskyB.,Sullivan R. M.(2013)Inappropriatesinustachycardia.J AmCollCardiol61:793–801.

63.Klein I., Ojamaa K.(2001) Thyroid hormone and the cardiovascular system.NEnglJMed344:501–509.

416

КЛИНИЧЕСКИЕРЕКОМЕНДАЦИИПОПРОВЕДЕНИЮ ЭЛЕКТРОФИЗИОЛОГИЧЕСКИХПРОЦЕДУР УПАЦИЕНТОВСНАРУШЕНИЯМИРИТМАСЕРДЦА

64.Cappato R., Castelvecchio S., Ricci C., et al.(2012) Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective,randomized,placebo-controlled,double-blind,crossover evaluation.JAmCollCardiol60:1323–1329

65.Benezet-Mazuecos J., Rubio J. M., Farré J., et al.(2013) Longterm outcomes of ivabradine in inappropriate sinus tachycardia patients:appropriateefficacyorinappropriatepatients.PacingClin Electrophysiol36:830–836.

66.PtaszynskiP.,KaczmarekK.,RutaJ.,etal.(2013)Metoprololsuccinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy. Europace15:116–121

67.Ptaszynski P., Kaczmarek K., Ruta J., et al. (2013) Ivabradine in the treatment of inappropriate sinus tachycardia in patients after successfulradiofrequencycatheterablationofatrioventricularnode slowpathway.PacingClinElectrophysiol36:42–49.

68.Ptaszynski P., Kaczmarek K., Ruta J., et al.(2013) Ivabradine in combination with metoprolol succinate in the treatment of inappropriatesinustachycardia.JCardiovascPharmacolTher18:338– 344.

69.Calò L., Rebecchi M., Sette A., et al.(2010) Efficacy of ivabradine administrationinpatientsaffectedbyinappropriatesinustachycardia. HeartRhythm7:1318–1323.

70.Kaplinsky E., Comes F. P., Urondo L. S.V., et al. (2010) Efficacy of ivabradine in four patients with inappropriate sinus tachycardia: a threemonth-longexperiencebasedonelectrocardiographic,Holter monitoring,exercisetoleranceandqualityoflifeassessments.Cardiol J17:166–171.

71.RakovecP.(2009)Treatmentofinappropriatesinustachycardiawith ivabradine.WienKlinWochenschr121:715–718

72.Zellerhoff S., Hinterseer M., Felix Krull B., et al. (2010) Ivabradine in patientswithinappropriatesinustachycardia.NaunynSchmiedebergs ArchPharmacol382:483–486

73.Chen S. A., Chiang C. E., Yang C. J., et al.(1994) Sustained atrial tachycardia in adult patients. Electrophysiological characteristics, pharmacological response, possible mechanisms, and effects of radiofrequencyablation.Circulation90:1262–1278.

417

ГЛАВА3

74.Law I. H.,VonBergen N. H.,Gingerich J. C.,etal.(2006)Transcatheter cryothermalablationofjunctionalectopictachycardiainthenormal heart.HeartRhythm3:903–907.

75.Kistler P. M., Sanders P., Fynn S. P., et al. (2003) Electrophysiological and electrocardiographic characteristics of focal atrial tachycardia originatingfromthepulmonaryveins:acuteandlong-termoutcomes ofradiofrequencyablation.Circulation108:1968–1975.

76.Markowitz S. M.,Stein K. M.,MittalS.,etal.(1999)Differentialeffectsof adenosineonfocalandmacroreentrantatrialtachycardia.JCardiovasc Electrophysiol10:489–502.

77.ReisingerJ.,GstreinC.,WinterT.,etal.(2010)Optimizationofinitial energy for cardioversion of atrial tachyarrhythmias with biphasic shocks.AmJEmergMed28:159–165

78.Engelstein E. D., Lippman N., Stein K. M., et al. (1994) Mechanismspecificeffectsofadenosineonatrialtachycardia.Circulation89:2645– 2654.

79.EidherU.,FreihoffF.,KaltenbrunnerW.,etal.(2006)Efficacyandsafety of ibutilide for the conversion of monomorphic atrial tachycardia. PacingClinElectrophysiol29:358–362.

80.de Loma-Osorio F., Diaz-Infante E., et al. (2013) Spanish Catheter Ablation Registry. 12th Official Report of the Spanish Society of Cardiology Working Group on Electrophysiology and Arrhythmias (2012).RevEspCardiol(EnglEd)66:983–992.

81.Biviano A. B.,BainW.,WhangW.,etal.(2012)Focalleftatrialtachycardias notassociatedwithpriorcatheterablationforatrialfibrillation:clinical andelectrophysiologicalcharacteristics.PacingClinElectrophysiol 35:17–27.

82.Kalman J. M.,Olgin J. E.,Karch M. R.,etal.(1998)»Cristaltachycardias»: originofrightatrialtachycardiasfromthecristaterminalisidentified byintracardiacechocardiography.JAmCollCardiol31:451–459.

83.Kistler P. M., Sanders P., Fynn S. P., et al. (2003) Electrophysiological and electrocardiographic characteristics of focal atrial tachycardia originatingfromthepulmonaryveins:acuteandlong-termoutcomes ofradiofrequencyablation.Circulation108:1968–1975.

84.Sheldon R. S.,Grubb B. P.,OlshanskyB.,etal.(2015)2015HeartRhythm Societyexpertconsensusstatementonthediagnosisandtreatment ofposturaltachycardiasyndrome,inappropriatesinustachycardia, andvasovagalsyncope.HeartRhythm12:e41–e63.

418

КЛИНИЧЕСКИЕРЕКОМЕНДАЦИИПОПРОВЕДЕНИЮ ЭЛЕКТРОФИЗИОЛОГИЧЕСКИХПРОЦЕДУР УПАЦИЕНТОВСНАРУШЕНИЯМИРИТМАСЕРДЦА

85.Liu X.,DongJ.,Ho S. Y.,etal.(2010)Atrialtachycardiaarisingadjacent tononcoronaryaorticsinus:distinctiveatrialactivationpatternsand anatomicinsights.JAmCollCardiol56:796–804.

86.Morton J. B.,SandersP.,DasA.,etal.(2001)Focalatrialtachycardia arising from the tricuspid annulus: electrophysiologic and electrocardiographic characteristics. J Cardiovasc Electrophysiol 12:653–659.

87.Field J. M., Hazinski M. F., Sayre M. R., et al. (2010) Part 1: executive summary: 2010 American Heart Association guidelines for cardiopulmonaryresuscitationandemergencycardiovascularcare. Circulation122:S640–S656.

88.Orejarena L. A., Vidaillet H., DeStefano F., et al. (1998) Paroxysmal supraventricular tachycardia in the general population. J Am Coll Cardiol31:150–157.

89.CalkinsH.,SousaJ.,el-AtassiR.,etal.(1991)Diagnosisandcureof theWolff-Parkinson-Whitesyndromeorparoxysmalsupraventricular tachycardias during a single electrophysiologic test. N Engl J Med 324:1612–1618.

90.Kay G. N.,Epstein A. E.,Dailey S. M.,etal.(1993)Roleofradiofrequency ablation in the management of supraventricular arrhythmias: experiencein760consecutivepatients.JCardiovascElectrophysiol 4:371–389.

91.Lindsay B. D.,Chung M. K.,Gamache M. C.,etal.(1993)Therapeutic end points for the treatment of atrioventricular node reentrant tachycardia by catheter-guided radiofrequency current. J Am Coll Cardiol22:733–740.

92.Jackman W. M.,Beckman K. J.,McClellandJ.H.,etal.(1992)Treatment ofsupraventriculartachycardiaduetoatrioventricularnodalreentry, byradiofrequencycatheterablationofslow-pathwayconduction.N EnglJMed327:313–318.

93.von Bernuth G., Engelhardt W., Kramer H. H., et al. (1992) Atrial automatictachycardiaininfancyandchildhood.EurHeartJ13:1410– 1415.

94.Chen S. A.,Chiang C. E.,Yang C. J.,etal.(1994)Accessory pathway and atrioventricularnodereentranttachycardia inelderly patients: clinical features, electrophysiologic characteristics and results of radiofrequencyablation.JAmCollCardiol23:702–708

419

ГЛАВА3

95.Rodriguez L. M.,deChillouC.,SchläpferJ.,etal.(1992)Ageatonsetand genderofpatientswithdifferenttypesofsupraventriculartachycardias. AmJCardiol70:1213–1215.

96.Clair W. K.,Wilkinson W. E.,McCarthyE.A.,etal.(1993)Spontaneous occurrenceofsymptomaticparoxysmalatrialfibrillationandparoxysmal supraventriculartachycardiainuntreatedpatients.Circulation87:1114– 1122.

97.Wu D.,Yeh S. J.,Wang C. C.,etal.(1993)Asimpletechniqueforselective radiofrequencyablationoftheslowpathwayinatrioventricularnode reentranttachycardia.JAmCollCardiol21:1612–1621.

98.CoumelP.,FidelleJ.(1980)Amiodaroneinthetreatmentofcardiac arrhythmias in children: one hundred thirty-five cases. Am Heart J 100:1063–1069.

99.MiyazakiA.,OhuchiH.,KurosakiK.,etal.(2008)Efficacyandsafetyof sotalolforrefractorytachyarrhythmiasincongenitalheartdisease. CircJ72:1998–2003.

100.Kang K. T., Etheridge S. P., Kantoch M. J., et al. (2014) Current management of focal atrial tachycardia in children: a multicenter experience.CircArrhythmElectrophysiol7:664–670.

101.Arsura E. L., Solar M., Lefkin A. S., et al. (1987) Metoprolol in the treatmentofmultifocalatrialtachycardia.CritCareMed15:591–594.

102.Levine J. H.,Michael J. R.,GuarnieriT.(1985)Treatmentofmultifocal atrialtachycardiawithverapamil.NEnglJMed312:21–25.

103.alerno D.M., Anderson B., Sharkey P. J., et al. (1987) Intravenous verapamilfortreatmentofmultifocalatrialtachycardiawithandwithout calciumpretreatment.AnnInternMed107:623–628.

104.Hazard P. B., Burnett C. R. (1987) Verapamil in multifocal atrial tachycardia.Hemodynamicandrespiratorychanges.Chest91:68–70.

105.Hazard P. B., Burnett C. R. (1987) Treatment of multifocal atrial tachycardiawithmetoprolol.CritCareMed15:20–25.

106.Kastor J. A.(1990)Multifocalatrialtachycardia.NEnglJMed322:1713– 1717.

107.MehtaD.,WafaS.,Ward D. E.,etal.(1988)Relativeefficacyofvarious physical manoeuvres in the termination of junctional tachycardia. Lancet1:1181–1185.

108.Wen Z. C., Chen S. A., Tai C. T., et al. (1998) Electrophysiological mechanismsanddeterminantsofvagalmaneuversfortermination ofparoxysmalsupraventriculartachycardia.Circulation98:2716–2723.

420